191 related articles for article (PubMed ID: 25866838)
1. Attention deficit-hyperactivity disorder symptoms and daytime voiding symptoms in children with primary enuresis: an observational study to evaluate the effectiveness of desmopressin treatment.
Yang TK; Guo YJ; Chang HC; Yang HJ; Huang KH
ScientificWorldJournal; 2015; 2015():356121. PubMed ID: 25866838
[TBL] [Abstract][Full Text] [Related]
2. A retrospective observational study of enuresis, daytime voiding symptoms, and response to medical therapy in children with attention deficit hyperactivity disorder and autism spectrum disorder.
Gor RA; Fuhrer J; Schober JM
J Pediatr Urol; 2012 Jun; 8(3):314-7. PubMed ID: 21131234
[TBL] [Abstract][Full Text] [Related]
3. Treatment of nocturnal enuresis in children with attention deficit hyperactivity disorder.
Chertin B; Koulikov D; Abu-Arafeh W; Mor Y; Shenfeld OZ; Farkas A
J Urol; 2007 Oct; 178(4 Pt 2):1744-7. PubMed ID: 17707010
[TBL] [Abstract][Full Text] [Related]
4. Correlation between symptoms of voiding dysfunction and attention deficit disorder with hyperactivity in children with lower urinary tract symptoms.
Yang TK; Guo YJ; Chen SC; Chang HC; Yang HJ; Huang KH
J Urol; 2012 Feb; 187(2):656-61. PubMed ID: 22177910
[TBL] [Abstract][Full Text] [Related]
5. Predictive parameters of response to desmopressin in primary nocturnal enuresis.
Van Herzeele C; Evans J; Eggert P; Lottmann H; Norgaard JP; Vande Walle J
J Pediatr Urol; 2015 Aug; 11(4):200.e1-8. PubMed ID: 26059526
[TBL] [Abstract][Full Text] [Related]
6. Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis.
Berkenwald A; Pires J; Ellsworth P
J Pediatr Urol; 2016 Aug; 12(4):220.e1-6. PubMed ID: 27373215
[TBL] [Abstract][Full Text] [Related]
7. Attention-deficit/hyperactivity disorder and enuresis: a study about effectiveness of treatment with methylphenidate or desmopressin in a pediatric population.
Ferrara P; Sannicandro V; Ianniello F; Quattrocchi E; Sbordone A; Petitti T; Mariotti P
Minerva Pediatr; 2019 Apr; 71(2):135-138. PubMed ID: 28260347
[TBL] [Abstract][Full Text] [Related]
8. Tailoring treatment of monosymptomatic nocturnal enuresis: the role of maximum voided capacity.
Tauris LH; Kamperis K; Hagstroem S; Bower WF; Rittig S
J Urol; 2012 Feb; 187(2):664-9. PubMed ID: 22177206
[TBL] [Abstract][Full Text] [Related]
9. The role of bladder capacity in antidiuretic and anticholinergic treatment for nocturnal enuresis.
Radvanska E; Kovács L; Rittig S
J Urol; 2006 Aug; 176(2):764-8; discussion 768-9. PubMed ID: 16813940
[TBL] [Abstract][Full Text] [Related]
10. Incontinence in children with treated attention-deficit/hyperactivity disorder.
Niemczyk J; Equit M; Hoffmann L; von Gontard A
J Pediatr Urol; 2015 Jun; 11(3):141.e1-6. PubMed ID: 25863677
[TBL] [Abstract][Full Text] [Related]
11. Children with nocturnal enuresis and attention deficit hyperactivity disorder: A separate entity?
Kovacevic L; Wolfe-Christensen C; Rizwan A; Lu H; Lakshmanan Y
J Pediatr Urol; 2018 Feb; 14(1):47.e1-47.e6. PubMed ID: 28867160
[TBL] [Abstract][Full Text] [Related]
12. Combination of the enuresis alarm and desmopressin: second line treatment for nocturnal enuresis.
Kamperis K; Hagstroem S; Rittig S; Djurhuus JC
J Urol; 2008 Mar; 179(3):1128-31. PubMed ID: 18206924
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG
J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Lower Urinary Tract Symptoms in Children with Attention-Deficit/Hyperactivity Disorder: Comparison of Hospital and Population-Based Cohorts of 13,000 Patients.
Yang TK; Huang WY; Guo YJ; Chen YF; Chang HC; Huang KH
J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362621
[TBL] [Abstract][Full Text] [Related]
15. Comparison of long-term efficacy of desmopressin lyophilisate and enuretic alarm for monosymptomatic enuresis and assessment of predictive factors for success: a randomized prospective trial.
Önol FF; Guzel R; Tahra A; Kaya C; Boylu U
J Urol; 2015 Feb; 193(2):655-61. PubMed ID: 25158273
[TBL] [Abstract][Full Text] [Related]
16. A survey of voiding dysfunction in children with attention deficit-hyperactivity disorder.
Duel BP; Steinberg-Epstein R; Hill M; Lerner M
J Urol; 2003 Oct; 170(4 Pt 2):1521-3; discussion 1523-4. PubMed ID: 14501650
[TBL] [Abstract][Full Text] [Related]
17. Correlation between clinical manifestations of nocturnal enuresis and attentional performance in children with attention deficit hyperactivity disorder (ADHD).
Yang TK; Huang KH; Chen SC; Chang HC; Yang HJ; Guo YJ
J Formos Med Assoc; 2013 Jan; 112(1):41-7. PubMed ID: 23332428
[TBL] [Abstract][Full Text] [Related]
18. Commentary to 'A retrospective observational study of enuresis, daytime voiding symptoms, and response to medical therapy in children with attention deficit hyperactivity disorder and autism spectrum disorder'.
Nappo S
J Pediatr Urol; 2012 Jun; 8(3):318-9. PubMed ID: 21095161
[No Abstract] [Full Text] [Related]
19. Desmopressin and oxybutynin in monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial and an assessment of predictive factors.
Montaldo P; Tafuro L; Rea M; Narciso V; Iossa AC; Del Gado R
BJU Int; 2012 Oct; 110(8 Pt B):E381-6. PubMed ID: 22313792
[TBL] [Abstract][Full Text] [Related]
20. The effect of maximum voided volume on response to desmopressin therapy in children with enuresis.
Okur M; Ozen SF; Kocabay K; Cam K; Ozkan A; Uzun H
J Nippon Med Sch; 2012; 79(4):255-8. PubMed ID: 22976603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
